Stockscreener 앱 받기
12.34
0.40%
-0.05
시장 영업 전:
12.29
-0.05
-0.41%
Amneal Pharmaceuticals Inc 주식(AMRX)의 최신 뉴스
How Amneal’s Margin-Focused 2026 Outlook and 2025 Results Could Impact Amneal Pharmaceuticals (AMRX) Investors - simplywall.st
AMRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Are Options Traders Betting on a Big Move in Amneal Pharmaceuticals Stock? - MSN
Amneal Pharmaceuticals, Inc. (AMRX) added to S&P SmallCap 600 Index, boosting investor visibility - MSN
Hydroxychloroquine Market Is Booming So Rapidly | Sanofi and Amneal Pharmaceuticals, LLC - openPR.com
Stock Recap: Is Amneal Pharmaceuticals Inc in a long term uptrend2026 Fundamental Recap & Long-Term Investment Growth Plans - baoquankhu1.vn
Aug Analyst Calls: What are the future prospects of Amneal Pharmaceuticals IncPortfolio Gains Report & Weekly High Return Stock Opportunities - baoquankhu1.vn
Retail Surge: Will Amneal Pharmaceuticals Inc benefit from green energy policies2026 Winners & Losers & Community Verified Swing Trade Signals - baoquankhu1.vn
Amneal Pharmaceuticals: Flattish 2026 Revenue Growth Aside, Stock Still Looks A Buy (AMRX) - Seeking Alpha
Algert Global LLC Cuts Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Amneal Recalls Three Lots Of UTI Drug Over Concerns of Microbial Contamination: Retail Sticks To Bearish Territory - MSN
Capula Management Ltd Buys New Shares in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
AMRX PE Ratio & Valuation, Is AMRX Overvalued - Intellectia AI
Is Amneal Pharmaceuticals (AMRX) Pricing Reflect Its DCF Gap And Recent Share Slide - Yahoo Finance
Fed Meeting: Does Amneal Pharmaceuticals Inc stock have upside surprise potential2026 Weekly Recap & Community Consensus Trade Alerts - baoquankhu1.vn
Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Down 5.5%Here's What Happened - MarketBeat
Amneal Pharmaceuticals Inc (AMRX) Shares Gap Down to $12.73 on M - GuruFocus
Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment - Yahoo Finance
What Amneal Pharmaceuticals (AMRX)'s Return to Profitability and 2026 Guidance Means For Shareholders - simplywall.st
Amneal Pharmaceuticals Conference: “Amneal 2.0” Targets 2026 Growth in Biosimilars, CREXONT and AvKARE Shift - MarketBeat
Amneal (AMRX) Stock Analysis 2026: Strong Gains vs. Future Growth ConcernsNews and Statistics - IndexBox
Shorts Report: Is Amneal Pharmaceuticals Inc a strong candidate for buy and holdForecast Cut & Weekly Stock Breakout Alerts - baoquankhu1.vn
3 Reasons to Avoid AMRX and 1 Stock to Buy Instead - Finviz
AMRX: Biosimilars and specialty launches fuel growth, with profitability and global expansion accelerating - TradingView
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Reassessing Amneal Pharmaceuticals (AMRX) Valuation After Strong Long Term Returns And A High Current P/E Ratio - Sahm
Best Value Stocks to Buy for March 9th - The Globe and Mail
Take the Zacks Approach to Beat the Markets: Amneal Pharmaceuticals, Leidos & Vishay Precision in Focus - MSN
Trade Report: Will Amneal Pharmaceuticals Inc benefit from current market trends2026 Big Picture & Verified Trade Idea Suggestions - baoquankhu1.vn
Citigroup Inc. Purchases 101,166 Shares of Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Amneal Pharmaceuticals Earnings Call: Growth Amid Transition - The Globe and Mail
Amneal Pharmaceuticals, Inc. $AMRX Shares Sold by Quantbot Technologies LP - MarketBeat
Goldman Sachs Reaffirms Their Buy Rating on Amneal Pharmaceuticals (AMRX) - The Globe and Mail
Amneal to Participate in Upcoming Investor Conference - National Today
Amneal (AMRX) Co-CEO gains shares via RSU and performance awards - Stock Titan
Amneal (AMRX) EVP nets stock from RSU vesting and tax withholdings - Stock Titan
AMRX SEC FilingsAmneal Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Amneal (AMRX) Co-CEO Chintu Patel gets major RSU and PSU grants - Stock Titan
Amneal (AMRX) Co-CEO awarded time- and performance-based RSUs - Stock Titan
Amneal (NYSE: AMRX) EVP awarded time- and performance-based RSUs - Stock Titan
Amneal (NYSE: AMRX) CFO granted time- and performance-based RSUs - Stock Titan
Amneal (NYSE: AMRX) grants RSU and performance stock awards to EVP - Stock Titan
Amneal (NYSE: AMRX) EVP Andrew Boyer granted time- and performance-based RSUs - Stock Titan
AMRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Amneal Pharmaceuticals, Inc. $AMRX Shares Purchased by Vanguard Group Inc. - MarketBeat
Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Exploring A 19% Upside Potential - DirectorsTalk Interviews
Short Interest in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Drops By 16.4% - MarketBeat
Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Concentra Group Holdings Parent, Inc. (CON) and Opus Genetics (IRD) - The Globe and Mail
Truist raises Amneal Pharmaceuticals stock price target on margin focus By Investing.com - Investing.com Canada
Truist raises Amneal Pharmaceuticals stock price target on margin focus - Investing.com
Truist Adjusts Price Target on Amneal Pharmaceuticals to $17 From $15, Maintains Buy Rating - marketscreener.com
Truist Financial Issues Positive Forecast for Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price - MarketBeat
Amneal Q4 2025 Highlights Shift Toward Higher Value Pharma Segments - simplywall.st
Earnings Miss: Can Amneal Pharmaceuticals Inc be the next market leaderQuarterly Portfolio Review & Daily Growth Stock Tips - baoquankhu1.vn
A Look At Amneal Pharmaceuticals (AMRX) Valuation After Recent Share Price Weakness - Yahoo Finance
Envestnet Asset Management Inc. Takes $1.61 Million Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Q4 2025 Earnings Call Transcript - Insider Monkey
Amneal Pharmaceuticals (AMRX) Return To Profit Tests High 60.3x P/E Narrative - Sahm
The Bull Case For Amneal Pharmaceuticals (AMRX) Could Change Following New 2026 Revenue Guidance Release - simplywall.st
Earnings call transcript: Amneal Pharmaceuticals beats expectations in Q4 2025 - Investing.com Australia
Why Amneal (AMRX) Stock Is Trading Lower Today - Yahoo Finance
Amneal Pharmaceuticals (NASDAQ:AMRX) Releases FY 2026 Earnings Guidance - MarketBeat
Amneal Pharmaceuticals (NASDAQ: AMRX) grows biosimilars, Parkinson’s and injectables - Stock Titan
2.02%
0.77%
자본화:
|
볼륨(24시간):